MorphoSys AG (XSWX:MOR) Days Payable : 176.77 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is MorphoSys AG Days Payable?

MorphoSys AG's average Accounts Payable for the three months ended in Dec. 2023 was CHF26.8 Mil. MorphoSys AG's Cost of Goods Sold for the three months ended in Dec. 2023 was CHF13.8 Mil. Hence, MorphoSys AG's Days Payable for the three months ended in Dec. 2023 was 176.77.

The historical rank and industry rank for MorphoSys AG's Days Payable or its related term are showing as below:

XSWX:MOR' s Days Payable Range Over the Past 10 Years
Min: 209.44 Med: 555.56 Max: 1202.14
Current: 524.66

During the past 13 years, MorphoSys AG's highest Days Payable was 1202.14. The lowest was 209.44. And the median was 555.56.

XSWX:MOR's Days Payable is ranked better than
75.59% of 717 companies
in the Biotechnology industry
Industry Median: 152.89 vs XSWX:MOR: 524.66

MorphoSys AG's Days Payable declined from Dec. 2022 (226.83) to Dec. 2023 (176.77). It may suggest that MorphoSys AG accelerated paying its suppliers.

MorphoSys AG Days Payable Historical Data

The historical data trend for MorphoSys AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MorphoSys AG Days Payable Chart

MorphoSys AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

273.51

1,165.39

699.79

436.87

215.04

MorphoSys AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															226.83	407.98	1,608.00	735.72	176.77

Competitive Comparison of MorphoSys AG's Days Payable

For the Biotechnology subindustry, MorphoSys AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MorphoSys AG's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MorphoSys AG's Days Payable distribution charts can be found below:

* The bar in red indicates where MorphoSys AG's Days Payable falls into.

MorphoSys AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

MorphoSys AG's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (38.072	+	26.772)	/	2 )	/	55.032	*	365
=	32.422					/	55.032	*	365
=	215.04

MorphoSys AG's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	26.772)	/	1 )	/	13.82	*	365 / 4
=	26.772					/	13.82	*	365 / 4
=	176.77

MorphoSys AG Days Payable Related Terms

Thank you for viewing the detailed overview of MorphoSys AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

MorphoSys AG (XSWX:MOR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MorphoSys AG (XSWX:MOR) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MPSYF:USA MOR:USA 1MOR:Italy MORd:UK 0NDV:UK MOR:Germany MOR:Austria

Address

Semmelweisstrasse 7, Planegg, BY, DEU, 82152

Website

https://www.morphosys.com

MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.